Cancer is a growing health concern across Southeast Asia. As populations increase and healthcare systems face rising demand, access to advanced cancer treatment technologies—especially radiotherapy—has become a priority. In this evolving landscape, the India ASEAN FTA is playing a meaningful role by improving the movement of medical equipment, including the linac machine, across borders.
For India-based healthcare solution providers like Global CanCare Pvt. Ltd., the ASEAN FTA creates new opportunities to support cancer centres across Southeast Asia with reliable, cost-effective, and clinically proven radiotherapy infrastructure.
Understanding the India ASEAN FTA (AITIGA)
The India–ASEAN Free Trade Agreement, also known as AITIGA, was established to promote economic cooperation between India and the ten ASEAN member countries. By reducing tariffs and improving market access, the agreement encourages regional collaboration in key sectors, including healthcare and medical devices.
For cancer care providers, this means that advanced radiotherapy equipment from India can reach ASEAN markets more efficiently, helping hospitals modernise their treatment capabilities.
Why is the Linac Machine Central to Radiotherapy Expansion?
The linac machine (linear accelerator) is the backbone of modern radiation oncology. It allows precise targeting of tumours while minimising damage to surrounding healthy tissue. As treatment standards improve across ASEAN countries, the demand for linac-based radiotherapy is increasing sharply.
However, radiotherapy is not just about purchasing a linac machine—it requires bunker construction, shielding, installation, commissioning, and long-term technical support. This is where integrated solution providers like Global CanCare Pvt. Ltd., bring real value.
Trade Benefits that Translate into Healthcare Impact
The ASEAN FTA enables several practical advantages that directly support Global CanCare’s work across Southeast Asia:
- Lower import duties on radiotherapy equipment
- Faster customs clearance and logistics
- Easier collaboration with regional healthcare partners
- Greater confidence in Indian medical manufacturing
Combined with India’s Production Linked Incentive (PLI) scheme for medical devices, these benefits strengthen India’s position as a trusted source of radiation oncology solutions.
Global CanCare’s Role in the India–ASEAN Healthcare Corridor
Global CanCare Pvt. Ltd, an India-based healthcare company, works at the intersection of technology, infrastructure, and regional collaboration. Leveraging the benefits of the India ASEAN FTA, Global CanCare supports hospitals and cancer centres by delivering:
- Advanced linear accelerators (LINACs)
- Cost-effective, patented radiotherapy bunker construction technologies
- Radiation oncology equipment
- End-to-end, turnkey cancer care solutions
By operating within the ASEAN FTA framework, Global CanCare helps healthcare providers reduce project costs, shorten timelines, and ensure dependable access to radiotherapy systems.
How the ASEAN FTA Supports Medical Equipment Access
The ASEAN FTA offers several advantages that directly impact healthcare delivery:
- Reduced or eliminated tariffs on medical devices
- Faster customs and smoother logistics
- Improved confidence in regional supply chains
- Greater collaboration between manufacturers and healthcare providers
These benefits are especially important for complex systems such as linac machines, which require not only equipment delivery but also installation, commissioning, and long-term support.
Beyond Equipment: Building Sustainable Radiotherapy Centres
One of the key challenges in Southeast Asia is creating radiotherapy centres that are not only installed quickly but also operate reliably over time. Global CanCare’s approach focuses on sustainability—helping hospitals plan infrastructure, meet regulatory requirements, and maintain systems long after installation.
“Global CanCare works closely with hospitals, cancer centres, and healthcare to support sustainable radiotherapy infrastructure.”
This experience is increasingly relevant for ASEAN healthcare systems seeking dependable long-term partners rather than transactional suppliers.
Conclusion: India ASEAN FTA
The India ASEAN FTA is more than a trade agreement—it is a practical enabler of better cancer care. By supporting affordable, faster, and trusted access to technologies like the linac machine, the agreement allows healthcare providers to expand radiotherapy services with confidence.
Contact Us:
- Call: 9522982211
- Website: Global CanCare Pvt Ltd